We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$187M
AUM Growth
+$35.7M
Cap. Flow
+$24M
Cap. Flow %
12.84%
Top 10 Hldgs %
26.94%
Holding
934
New
114
Increased
345
Reduced
72
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.57M
2
AAPL icon
Apple
AAPL
+$873K
3
V icon
Visa
V
+$710K
4
XOM icon
ExxonMobil
XOM
+$669K
5
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$654K

Sector Composition

Rank Sector Weight
1 Technology 9.29%
2 Financials 7.79%
3 Healthcare 6.4%
4 Communication Services 4.68%
5 Industrials 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
751
Labcorp
LH
$23.9B
$3.21K ﹤0.01%
22
AES icon
752
AES
AES
$10.6B
$3.01K ﹤0.01%
151
+1
+0.7% +$18
UBER icon
753
Uber
UBER
$140B
$2.97K ﹤0.01%
100
-100
-50% -$2.97K
SPTL icon
754
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.4B
$2.95K ﹤0.01%
+76
New +$3.04K
PDBC icon
755
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$5.85B
$2.94K ﹤0.01%
177
+2
+1% +$32
AIG icon
756
American International
AIG
$41.4B
$2.93K ﹤0.01%
57
+12
+27% +$636
NWL icon
757
Newell Brands
NWL
$2.14B
$2.88K ﹤0.01%
150
ZUO
758
DELISTED
Zuora, Inc.
ZUO
$2.87K ﹤0.01%
+200
New +$2.93K
NRO
759
Neuberger Real Estate Securities Income Fund Inc
NRO
$190M
$2.79K ﹤0.01%
+524
New +$2.81K
IOVA icon
760
Iovance Biotherapeutics
IOVA
$2.29B
$2.77K ﹤0.01%
100
GIGB icon
761
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$958M
$2.73K ﹤0.01%
+52
New +$2.73K
ETN icon
762
Eaton
ETN
$161B
$2.71K ﹤0.01%
29
+1
+4% +$89
SWN
763
DELISTED
Southwestern Energy Company
SWN
$2.66K ﹤0.01%
1,100
FNDX icon
764
Schwab Fundamental US Large Company Index ETF
FNDX
$26.3B
$2.65K ﹤0.01%
186
ERIC icon
765
Ericsson
ERIC
$30.6B
$2.63K ﹤0.01%
300
BOCT icon
766
Innovator US Equity Buffer ETF October
BOCT
$283M
$2.62K ﹤0.01%
+100
New +$2.55K
MCHP icon
767
Microchip Technology
MCHP
$44.2B
$2.51K ﹤0.01%
48
BMY.RT
768
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.41K ﹤0.01%
+800
New +$2.08K
ESLT icon
769
Elbit Systems
ESLT
$37.9B
$2.38K ﹤0.01%
15
EDIT icon
770
Editas Medicine
EDIT
$419M
$2.22K ﹤0.01%
75
SGMO
771
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.13K ﹤0.01%
255
GEM icon
772
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.66B
$2.13K ﹤0.01%
+62
New +$2.04K
GLOB icon
773
Globant
GLOB
$1.32B
$2.12K ﹤0.01%
20
IQ icon
774
iQIYI
IQ
$1.17B
$2.11K ﹤0.01%
100
APTV icon
775
Aptiv
APTV
$11.9B
$2.09K ﹤0.01%
22

Similar funds

Glen Eagle Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Glen Eagle Advisors held 934 positions worth $187M, up 24% from $151M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Glen Eagle Advisors deployed $24M of net new capital in Q4 2019, opening 114 new positions and adding to 345 existing holdings. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 10,743 shares worth $587K.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $211K trimmed.

  • Glen Eagle Advisors's largest Q4 2019 buy was iShares AAA-A Rated Corporate Bond ETF: 10,743 shares worth $587K.
  • Glen Eagle Advisors added most to Microsoft in Q4 2019, an estimated $1.57M increase.
  • Glen Eagle Advisors's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $211K.
  • Glen Eagle Advisors fully exited Invesco BulletShares 2019 Corporate Bond ETF in Q4 2019, selling an estimated $575K.
  • Glen Eagle Advisors's ten largest holdings make up 27% of its $187M portfolio in Q4 2019.
  • Glen Eagle Advisors opened 114 new positions and closed 33 in Q4 2019.
  • Glen Eagle Advisors's portfolio value rose 24% quarter-over-quarter to $187M.

Based on Glen Eagle Advisors's 13F filing for Q4 2019, filed 13 Aug 2024.